YCBD · XBRL financial data
cbdMD financial statements, every fiscal year
The same tables from 7 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (YCBD's year ends in late September)
| In thousands of dollars | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | †Sep 30, 2023 | Sep 30, 2024 | Sep 30, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 41,884 | 44,481 | 35,403 | 24,155 | 19,482 | 19,190 |
| Cost of revenue | 15,515 | 14,495 | 13,067 | 9,178 | 7,487 | 7,222 |
| Gross profit | 26,369 | 29,986 | 22,337 | 14,978 | 11,996 | 11,968 |
| Total operating expenses | 43,951 | 49,602 | — | — | — | — |
| Operating income (loss) | (17,582) | (19,616) | (78,267) | (22,488) | (3,315) | (2,163) |
| Other income (expense) | — | 29 | 239 | 0 | — | — |
| Income tax expense (benefit) | (1,345) | 895 | 0 | 0 | 0 | 0 |
| Net income (loss) | 12,602 | (23,395) | (70,084) | (22,938) | (3,700) | (2,041) |
| Earnings per share, basic USD per share | 0.28 | (0.47) | (1.24) | (13.32) | (1.79) | (1.09) |
| Earnings per share, diluted USD per share | 0.28 | (0.47) | (1.24) | (13.32) | (1.79) | (1.09) |
| Weighted average shares, basic thousands of shares | 44,140 | 54,938 | 59,750 | 2,022 | 4,313 | 4,023 |
| Weighted average shares, diluted thousands of shares | 45,172 | 54,938 | 59,750 | 2,022 | 4,313 | 4,023 |
- † Share count changed about 1/20 in the period ending 2023-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (YCBD's year ends in late September)
| In thousands of dollars | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | †Sep 30, 2023 | Sep 30, 2024 | Sep 30, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 14,825 | 26,411 | 6,720 | 1,798 | 2,453 | 2,261 |
| Marketable securities | 26 | 33 | 0 | — | — | — |
| Accounts receivable | — | — | 273 | 585 | 622 | 786 |
| Inventory | 4,892 | 5,573 | 4,767 | 4,236 | 2,524 | 2,947 |
| Prepaid and other current assets | — | 1,147 | 702 | 750 | 407 | 277 |
| Total current assets | 23,712 | 36,502 | 16,012 | 8,070 | 6,389 | 6,551 |
| Property and equipment, net | 3,183 | 2,562 | 823 | 717 | 454 | 277 |
| Right-of-use asset | 6,851 | 5,615 | 4,478 | 3,351 | 86 | 704 |
| Goodwill | 54,670 | 56,671 | 0 | 0 | — | 0 |
| Total assets | 110,843 | 124,883 | 40,792 | 16,195 | 10,581 | 10,420 |
| Accounts payable | 2,850 | 2,979 | 2,037 | 1,906 | 1,541 | 1,174 |
| Accrued liabilities | — | 2,728 | 2,061 | 1,484 | 633 | 736 |
| Total current liabilities | 7,689 | 6,917 | 5,286 | 4,670 | 8,618 | 3,194 |
| Long-term debt | 264 | 109 | 125 | 0 | — | — |
| Lease liability, non-current | 6,010 | 4,859 | 3,680 | 2,403 | 0 | 0 |
| Total liabilities | 31,661 | 21,741 | 9,367 | 7,164 | 8,618 | 3,194 |
| Accumulated deficit | (47,388) | (73,338) | (147,424) | (174,364) | (182,068) | (179,435) |
| Total stockholders' equity | 79,182 | 103,142 | 31,424 | 9,031 | 1,963 | 7,226 |
| Total liabilities and equity | 110,843 | 124,883 | 40,792 | 16,195 | 10,581 | 10,420 |
| Common shares outstanding (cover page) thousands of shares | 52,131 | 57,805 | 60,682 | 2,961 | 5,539 | 9,419 |
- † Share count changed about 1/20 in the period ending 2023-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (YCBD's year ends in late September)
| In thousands of dollars | Sep 30, 2020 | Sep 30, 2021 | Sep 30, 2022 | †Sep 30, 2023 | Sep 30, 2024 | Sep 30, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | 12,602 | (23,395) | (70,084) | (22,938) | (3,700) | (2,041) |
| Stock-based compensation | 1,900 | 1,298 | — | — | — | — |
| Depreciation and amortization | 721 | 1,017 | — | — | — | — |
| Net cash from operating activities | (10,664) | (14,093) | (14,967) | (4,302) | (353) | (1,452) |
| Purchases of property and equipment | — | 342 | 689 | 298 | 190 | 184 |
| Net cash from investing activities | (1,570) | (2,552) | (689) | 702 | (290) | (184) |
| Proceeds from issuing common stock | 16,766 | 0 | 0 | 2,478 | 50 | 0 |
| Dividends paid | 367 | 2,555 | — | — | — | — |
| Net cash from financing activities | 22,369 | 28,232 | (4,035) | (1,323) | 1,298 | 1,445 |
- † Share count changed about 1/20 in the period ending 2023-09-30, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 2844 and related industry codes, similar size; rows marked “added: same SIC” fill a short list. Each row is the latest quarter reported.
How peers are chosen
- SIC 2844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Fewer than three companies fall in that range, so the list adds same-SIC (2844) companies nearest in public float, each marked “added: same SIC”.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| cbdMD | 2,118 | 5,554 | (442)* | 11.2M | 4.8 quarters | 10-QJun 30, 2026 |
| Longevity Health Holdings | 35 | 396 | (224)* | 2.5M | 0.2 quarters | 10-QJun 30, 2026 |
| Caring Brands | 1,820 | not reported | (463)* | 10.4M | 3.9 quarters | 10-QJun 30, 2026 |
| DSwissadded: same SIC | 258 | 512 | 50* | 206.9M | — | 10-QJun 30, 2026 |
| Axil Brandsadded: same SIC | 7,929 | 6,090 | 3,763 | 6.8M | — | 10-QAug 31, 2026 |
| Solesenceadded: same SIC | 1,046 | 15,332 | 191* | 70.6M | — | 10-QJun 30, 2026 |
| Bonkadded: same SIC | 214 | 793 | (2,226)* | 8.0M | 0.1 quarters | 10-QJun 30, 2026 |
| Karbon-Xadded: same SIC | 335 | 344 | (1,198) | 109.2M | — | 10-Q/AAug 31, 2026 |
| United Guardianadded: same SIC | 2,391 | not reported | 1,520* | 4.6M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.